Retour sur lavenir.net
   CMB.TECH 17.580 € (-0,34 %)     ARGENX SE 868.800 € (-0,30 %)     D'IETEREN GROUP 165.300 € (+0,67 %)     AB INBEV 67.500 € (-0,15 %)     DECEUNINCK 2.480 € (0,00 %)     SYENSQO 78.350 € (+1,29 %)     SOLVAY 25.340 € (+0,80 %)     WDP 20.920 € (+1,26 %)     AEDIFICA 65.500 € (-0,15 %)     BEKAERT 37.850 € (+1,07 %)     ACKERMANS V.HAAREN 275.200 € (+1,40 %)     KBC 133.450 € (+1,79 %)     GBL 74.250 € (+0,54 %)     UMICORE 21.680 € (0,00 %)     UCB 212.200 € (+1,97 %)     BARCO 7.490 € (+3,60 %)     KBC ANCORA 95.700 € (+1,81 %)     AGFA-GEVAERT 0.386 € (+0,13 %)     AZELIS GROUP 12.010 € (0,00 %)     AGEAS 76.650 € (+1,05 %)     CENERGY 23.100 € (+4,90 %)     ELIA GROUP 119.800 € (-0,75 %)     MONTEA 64.400 € (+1,42 %)     FAGRON 21.950 € (0,00 %)     TITAN S.A. 49.400 € (+2,28 %)     OXURION 0.002 € (0,00 %)     BELYSSE GROUP 0.413 € (-1,67 %)     PROXIMUS 6.330 € (+1,44 %)     XIOR 25.150 € (-0,20 %)     LOTUS BAKERIES 12 360.000 € (+3,34 %)     SHURGARD 23.700 € (+0,21 %)     TUBIZE-FIN 179.800 € (+1,52 %)     SOFINA 247.400 € (+0,41 %)     KINEPOLIS GROUP 49.850 € (+0,30 %)     ECONOCOM GROUP 1.435 € (-2,38 %)     BREDERODE 105.600 € (0,00 %)     EVS 27.550 € (+0,18 %)     NYXOAH 1.302 € (-0,61 %)     IBA 15.220 € (-0,13 %)     INCLUSIO SA/NV 16.200 € (+0,31 %)     MELEXIS 67.600 € (+1,81 %)     VGP 71.700 € (0,00 %)     EKOPAK 3.415 € (-3,80 %)     BQUE NAT. BELGIQUE 361.000 € (+0,28 %)     COLRUYT 38.760 € (+0,83 %)     RECTICEL 12.660 € (+0,64 %)     GIMV 47.350 € (+2,27 %)     DEME GROUP 181.200 € (+0,22 %)     ONTEX GROUP 2.180 € (+2,83 %)     BANQUP GROUP 2.250 € (+4,17 %)     CELYAD ONCOLOGY 0.235 € (-2,08 %)     BPOST 1.234 € (+2,83 %)     ONWARD MEDICAL 2.950 € (+1,90 %)     TEXAF 37.000 € (-2,12 %)     TINC 11.020 € (0,00 %)     ORANGE BELGIUM 22.000 € (0,00 %)     IMMOBEL 18.550 € (-2,62 %)     CARE PROPERTY INV. 12.500 € (+0,81 %)     VIOHALCO 16.200 € (+5,74 %)     EXMAR 11.950 € (0,00 %)  
   COTY 2.080 € (-2,80 %)     CRCAM NORD CCI 28.590 € (-1,82 %)     EXOSENS 59.850 € (-1,32 %)     CIBOX INTER A CTIV 0.012 € (+7,83 %)     LOUIS HACHETTE 1.766 € (-0,06 %)     REMY COINTREAU 41.620 € (-0,24 %)     STELLANTIS NV 4.231 € (+0,76 %)     SOITEC 154.600 € (+9,65 %)     SANOFI 74.410 € (+0,49 %)     DANONE 60.160 € (-0,63 %)     TOTALENERGIES 79.010 € (-0,39 %)     KERING 227.700 € (-2,27 %)     UNILEVER 53.920 € (-0,20 %)     VALERIO TX 0.576 € (-1,37 %)     AIRBUS 193.820 € (+0,23 %)     KPN KON 4.054 € (+1,38 %)     STMICROELECTRONICS 44.570 € (+2,57 %)     AEGON 7.988 € (+1,11 %)     X-FAB 6.560 € (+7,54 %)     AHOLD DEL 31.860 € (+0,82 %)     RUBIS 35.780 € (+2,70 %)     CVC CAPITAL 12.710 € (+0,47 %)     ALSTOM 14.845 € (-2,85 %)     SHELL PLC 41.120 € (-0,47 %)     LEGRAND 138.900 € (+2,28 %)     BENETEAU 5.220 € (-0,38 %)     DSM FIRMENICH AG 93.580 € (+1,54 %)     SOCIETE GENERALE 73.990 € (+1,93 %)     L'OREAL 381.350 € (+1,41 %)     ARCADIS 42.780 € (+1,13 %)     ASM INTERNATIONAL 831.200 € (+2,14 %)     EDENRED 27.960 € (-1,48 %)     ASML HOLDING 1 477.600 € (+2,19 %)     BNP PARIBAS ACT.A 101.260 € (+0,52 %)     IMCD 94.640 € (+1,44 %)     WOLTERS KLUWER 67.380 € (-1,14 %)     SBM OFFSHORE 36.540 € (-0,16 %)     NN GROUP 81.080 € (+1,05 %)     ASR NEDERLAND 74.660 € (+0,78 %)     PHILIPS KON 21.630 € (+0,14 %)     CAPGEMINI 106.750 € (+2,30 %)     ABN AMRO BANK N.V. 43.830 € (+0,92 %)     AKZO NOBEL 56.220 € (+0,25 %)     ARCELORMITTAL SA 63.240 € (+0,19 %)     ING GROEP N.V. 32.225 € (+1,61 %)     UMG 14.730 € (-0,14 %)     MAGNUM 16.670 € (+1,24 %)     BE SEMICONDUCTOR 189.200 € (+1,37 %)     HEINEKEN 70.700 € (-0,06 %)     ORANGE 15.020 € (-0,07 %)     PROSUS 36.025 € (+0,49 %)     INPOST 15.570 € (-1,89 %)     RELX 29.060 € (-0,75 %)     LVMH 405.750 € (+0,73 %)     CAPITAL B 6.115 € (+7,47 %)     HERMES INTL 1 338.000 € (+0,49 %)     ACCOR 46.060 € (+1,05 %)     SAFRAN 327.700 € (+1,46 %)     FDJ UNITED 21.880 € (-0,14 %)     EUTELSAT COMMUNIC. 1.779 € (+1,48 %)  
News Réglementées
29/08/2026 04:05

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

EQS-News: INTCO Medical / Key word(s): Sales Result/Annual Results
INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

29.08.2026 / 04:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).

By the end of the reporting period, INTCO Medical's annualized production capacity for disposable gloves had reached 107 billion pieces. The total comprised 74 billion disposable nitrile gloves and 33 billion disposable vinyl gloves. This scale reinforces the Company's position as the world's largest producer of disposable gloves.

INTCO Medical's integrated value chain extends from nitrile latex and the research, development and manufacturing of core production equipment to glove production and global sales. Through nitrile latex manufacturers in which it holds controlling or equity interests, the Company strengthens raw material supply security, helping mitigate the impact of international crude oil price fluctuations on key raw material costs while enhancing supply stability and cost efficiency. Its coordinated domestic and international production capacity enables the Company to allocate manufacturing resources according to market demand, respond efficiently to customer needs and support reliable delivery across global markets. Together, these capabilities strengthen operational resilience.

During the reporting period, R&D expenses rose 20.62% to RMB 245.9 million (approx. US$36.6 million). The Company continued to develop high-performance products, including Syntex™ Synthetic Latex Gloves, a proprietary glove that does not contain natural latex proteins and offers high elasticity and puncture resistance, and Synmax Pro Exam Gloves, an enhanced vinyl glove for food service and industrial applications. The Company has also introduced safety work gloves, household gloves and other products to meet diverse application needs.

Smart manufacturing boosts efficiency and quality. INTCO Medical's latest nitrile glove production line spans more than 1.6 kilometers and incorporates about 500 control points. Its precision distributed control system automatically manages temperature and liquid levels based on production conditions, helping reduce labor and energy consumption while maintaining stable output. The Company's glove product yield remained above 99% during the reporting period.

INTCO Medical will continue optimizing global capacity and advancing protective product innovation to support growth.

Cision View original content:https://www.prnewswire.co.uk/news-releases/intco-medical-reports-40-6-h1-2026-revenue-growth-expands-worlds-largest-disposable-glove-capacity-to-107-billion-pieces-302863234.html

rt.gif?NewsItemId=EN35940&Transmission_Id=202608282158PR_NEWS_EURO_ND__EN35940&DateId=20260828


29.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2390642  29.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière